Xtx Topco LTD Astrazeneca PLC Transaction History

Xtx Topco LTD

$1.13 Billion
Q4 2024

A detailed history of Xtx Topco LTD transactions in Astrazeneca PLC stock. As of the latest transaction made, Xtx Topco LTD holds 59,101 shares of AZN stock, worth $4.5 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

59,101

Previous 32,530 81.68%

Holding current value

$4.5 Million

Previous $2.53 Million 52.8%

% of portfolio

0.34%

Previous 0.19%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$63.2 - $79.58 $1.68 Million - $2.11 Million	26,571 Added 81.68%	59,101 $3.87 Million
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $1.44 Million - $1.64 Million	18,751 Added 136.08%	32,530 $2.53 Million
Q2 2024 Aug 12, 2024	BUY	$66.81 - $80.83 $920,574 - $1.11 Million	13,779 New	13,779 $1.07 Million
Q4 2023 Feb 13, 2024	BUY	$61.89 - $69.28 $937,695 - $1.05 Million	15,151 New	15,151 $1.02 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $683,649 - $741,345	9,779 New	9,779 $699,000
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $1.27 Million - $1.64 Million	23,349 New	23,349 $1.58 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $373,160 - $447,968	-6,297 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $271,523 - $327,075	-4,873 Reduced 43.63%	6,297 $418,000
Q4 2021 Feb 11, 2022	BUY	$54.02 - $63.83 $603,403 - $712,981	11,170 New	11,170 $651,000
Q3 2021 Nov 12, 2021	SELL	$55.56 - $60.79 $930,074 - $1.02 Million	-16,740 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$48.42 - $60.18 $810,550 - $1.01 Million	16,740 New	16,740 $1 Million

Others Institutions Holding AZN

# of Institutions

1,365

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $236B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account